CompaniesMolecure
Molecure logo

Molecure

active
Warsaw, Poland
Founded 2012
Website
About

Novel therapeutics for neoplastic and inflammatory diseases

Areas of Focus

Categories

Small Molecule PharmaceuticalPoland
Team (15)
Agnieszka Motyl
Agnieszka Motyl
×Agnieszka Motyl, MD, PhDMEMBER OF THE SUPERVISORY BOARDAgnieszka Motyl, MD, PhD, MBAExpert with over 20 years of experience and extensive knowledge in the areas of business, change management,...
Molecure
team_member
Agnieszka Rajczuk-Szczepańska
Agnieszka Rajczuk-Szczepańska
×Agnieszka Rajczuk-SzczepańskaHR DIRECTORAgnieszka Rajczuk-Szczepańskacurrently serves asthe Human Resources(HR)Directorat Molecure. She has over 25 years of experience in HR, including over 10 years...
Molecure
team_memberfounderboard_member
Bart Lambrecht
Bart Lambrecht
×Bart LambrechtMD, PhDHe is a graduate of the University of Gent in Belgium, where he received his medical degree and PhD in 1993 and 1999. From 2002, he specialized in Pulmonary Medicine at Erasmus...
Molecure
team_member
Douglas Hay
Douglas Hay
×Douglas HayPhDDr. Douglas W.P. Hay obtained his PhD in Physiology and Pharmacology from the University of Strathclyde, Scotland. Douglas is a Pharmaceutical Executive with more than 20 years in Drug...
Molecure
team_memberexecutive
Luke O’Neill
Luke O’Neill
×Luke O’NeillPhDLuke O’Neill is Professor of Biochemistry in the School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute at Trinity College Dublin, Ireland. He is a world expert...
Molecure
team_memberfounder
Marcin Jan Szumowski
Marcin Jan Szumowski
×Marcin Jan SzumowskiPRESIDENT OF THE BOARD, CHIEF EXECUTIVE OFFICERMarcin has over 15 years of experience in technology transfer, R&D project and life science investment management. He has been...
Molecure
team_memberexecutive
View all 15 team members →
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

136

By Phase

PHASE2: 1PHASE1: 1

By Status

RECRUITING: 2

Recent Trials

NCT06205121Lead Sponsor
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis
PHASE2Recruiting
96 participants
Started: Mar 21, 2024 · Completed: Apr 30, 2026
NCT05759923Lead Sponsor
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours
PHASE1Recruiting
40 participants
Started: Jan 26, 2023 · Completed: Dec 31, 2025
Locations (1)
Headquarters
Warsaw, Poland
Map

Loading map...